Mid-cap biotech beats most of the big dogs with 21.9% revenue growth
09 April 2015
Who says bigger is better? According to a new report, mid-cap biotech companies are doing pretty well for themselves, thank you very much. Combined revenues for 35 mid-sized biotechs shot up by 21.9% last year, according to new research from GlobalData. The cohort hiked its revenue haul to $26.5 billion last year, up from $24.8 billion in 2013.
Second-quarter pharma market outlooks for pan-Asia mixed, India promising
08 April 2015
The 2015 second quarter bodes well for India, Taiwan, Malaysia and others, while Australia, Kuwait and Iran are not looking as healthy, according to the latest forecasts covering 11 countries of Asia and the Pacific region.
In a quiet move, India ends free drugs, diagnostics to public health units
08 April 2015
No fanfare, no press releases for this government action: India has decided to drop its three-year-old practice of providing free drugs and diagnostics in the nation's public health facilities. States instead would have the option of providing them on their own, a news report indicates.
South Korea struggles with healthcare needs of elderly
08 April 2015
South Korea has a wealth of statistics about the near future of healthcare needs in the country, but no apparent solutions for how to deal with an elderly population about to drain its coffers.
Use of Multivariate Data Analysis in Bioprocessing
08 April 2015
The ever increasing demand of biotherapeutics, together with the pressure to contain healthcare costs have motivated biotech manufacturers to focus on process optimization. Of a variety of approaches, use of advanced sampling techniques, new sensor technologies, and analyzers has emerged as a topic of interest to the scientific community at large. Implementation of these tools, however, inadvertently results in large complex datasets with underlying multivariate interactions.
Japanese researchers study carbon nanotubes with drug delivery applications
07 April 2015
Researchers across the world are scrambling to invent new technologies made out of graphene, perfectly flat sheets of carbon atoms that are only one atom thick. For instance, South Korea's Samsung is developing foldable screens made out of graphene, while the European Union is devoting €1 billion ($1.1 billion) to study the potential material of the future, which is a truly 2-D material, with no dangling bonds to bind with surfaces above or below it.
The top companies in med tech: 2014 revenue results
07 April 2015
Big med tech companies come in three types: med tech pure-plays; major conglomerates that include non-healthcare businesses; and mixed drug/device players. All three of these groups have been making big moves to transform themselves this year.
NIH Makes Initial Revisions to Guidelines for Genomic Data Analysis in the Cloud
06 April 2015
The National Institutes of Health issued a position statement this week revising its existing polices on use of cloud computing services for storing and analyzing controlled access data stored in the Database of Genotypes and Phenotypes (dbGAP).
06 April 2015
The Office of the National Coordinator for Health Information Technology (ONC) announced today the availability of online tools and resources designed to help states participating in the State Innovation Models initiative improve health care quality and lower costs.
Index Ventures banks ˆ650M for its new tech fund
06 April 2015
Index Ventures now has 650 million more euros to invest. The venture group, which has two big teams active on both sides of the Atlantic in life sciences as well as tech, filed documents with the SEC noting that its new Index Ventures Growth III--domiciled in Jersey--is fully sold.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Putin has stated that Russia will support Africa in the struggle against epidemics
19 April 2024
The Russian government has expanded the list of vital and essential drugs
19 April 2024
Achieving FAIR bacterial identification
18 April 2024
Unique testing regimen could prevent nuclease contamination
18 April 2024